English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17918/22933 (78%)
Visitors : 7417152      Online Users : 37
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CSMUIR > researcher portal > Artical >  Item 310902500/24650
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24650


    Title: Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study
    Authors: Chen, CL;Liou, JM;Lu, TM;Lin, YH;Wang, CK;Pan, TM
    Keywords: Microbiology;Food microbiology;Nutrition;Evidence-based medicine;Gut microflora;Immunity;Anti-oxidative capacity;Lactobacillus paracasei subsp. paracasei NTU 101;Probiotics
    Date: 2020
    Issue Date: 2022-08-09T08:05:47Z (UTC)
    Publisher: ELSEVIER SCI LTD
    Abstract: Vigiis 101-LAB capsules are produced from the fermentation of Lactobacillus paracasei subsp. paracasei NTU 101. We tested effects of Vigiis 101-LAB capsules I or II (5 or 10 billion CFU/day, respectively) on gut microflora in clinical trial I, and on peristalsis, immunity, and anti-oxidative capacity in clinical trial II, during a 4-week randomized, double-blind, placebo-controlled, adaptive-design study. In trial I, 36 subjects were divided into capsule I and placebo groups. After 4 weeks, Bifidobacterium spp. and Lactobacillus spp. counts were significantly higher in the feces of treatment subjects, with increases of 4.01- and 4.25-fold, respectively. In trial II, 52 subjects were divided into capsule II and placebo groups. After 4 weeks, the treatment group was found to have improved motility, decreased food transit time, and significantly increased immunoglobulin G, immunoglobulin M, and antioxidant activity. Thus, daily administration of Vigiis 101 capsule II can improve peristalsis, immunity, and anti-oxidative capacity.
    URI: http://dx.doi.org/10.1016/j.heliyon.2020.e04979
    https://www.webofscience.com/wos/woscc/full-record/WOS:000579136000210
    https://ir.csmu.edu.tw:8080/handle/310902500/24650
    Relation: HELIYON ,2020 ,v6 ,issue 9
    Appears in Collections:[researcher portal] Artical

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML159View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback